Emergent BioSolutions, Inc. (EBS)
7.05
+0.24
(+3.52%)
USD |
NYSE |
Oct 09, 16:00
7.085
+0.04
(+0.50%)
After-Hours: 16:50
Emergent BioSolutions 30-Day Average Daily Volume : 1.179M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.179M |
| October 07, 2026 | 1.180M |
| October 06, 2026 | 1.184M |
| October 05, 2026 | 1.151M |
| October 02, 2026 | 1.120M |
| October 01, 2026 | 1.150M |
| September 30, 2026 | 1.176M |
| September 29, 2026 | 1.176M |
| September 28, 2026 | 1.174M |
| September 25, 2026 | 1.188M |
| September 24, 2026 | 1.215M |
| September 23, 2026 | 1.242M |
| September 22, 2026 | 1.265M |
| September 21, 2026 | 1.371M |
| September 18, 2026 | 1.426M |
| September 17, 2026 | 1.505M |
| September 16, 2026 | 1.483M |
| September 15, 2026 | 1.446M |
| September 14, 2026 | 1.427M |
| September 11, 2026 | 1.420M |
| September 10, 2026 | 1.392M |
| September 09, 2026 | 1.332M |
| September 08, 2026 | 1.312M |
| September 04, 2026 | 1.310M |
| September 03, 2026 | 1.295M |
| Date | Value |
|---|---|
| September 02, 2026 | 1.280M |
| September 01, 2026 | 1.259M |
| August 31, 2026 | 1.241M |
| August 28, 2026 | 1.223M |
| August 27, 2026 | 1.201M |
| August 26, 2026 | 1.186M |
| August 25, 2026 | 1.176M |
| August 24, 2026 | 1.171M |
| August 21, 2026 | 1.164M |
| August 20, 2026 | 1.157M |
| August 19, 2026 | 1.128M |
| August 18, 2026 | 1.103M |
| August 17, 2026 | 1.101M |
| August 14, 2026 | 1.098M |
| August 13, 2026 | 1.081M |
| August 12, 2026 | 1.051M |
| August 11, 2026 | 1.018M |
| August 10, 2026 | 983138.0 |
| August 07, 2026 | 909359.0 |
| August 06, 2026 | 837046.2 |
| August 05, 2026 | 724794.5 |
| August 04, 2026 | 728451.1 |
| August 03, 2026 | 764083.4 |
| July 31, 2026 | 823683.9 |
| July 30, 2026 | 840464.8 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Exelixis, Inc. | 2.159M |
| Capricor Therapeutics, Inc. | 4.152M |
| ADMA Biologics, Inc. | 2.913M |
| Akebia Therapeutics, Inc. | 7.543M |
| Arcutis Biotherapeutics, Inc. | 2.997M |